Related Experiment Videos
Melittin as model system for probing interactions between proteins and cyclodextrins.
Mazdak Khajehpour1, Thomas Troxler, Vikas Nanda
1Department of Biochemistry and Biophysics, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. mazdak@mail.med.upenn.edu
Proteins
|March 30, 2004
Summary
Cyclodextrins, like hydroxypropyl-beta-cyclodextrin (HPBCD), prevent protein aggregation by interacting with hydrophobic regions. HPBCD was shown to inhibit melittin aggregation through intercalation of its aromatic tryptophan residue.
Area of Science:
- Biochemistry
- Supramolecular Chemistry
- Physical Chemistry
Background:
- Cyclodextrins are cyclic oligosaccharides with a hydrophilic exterior and hydrophobic interior.
- This structure allows cyclodextrins to encapsulate hydrophobic molecules in aqueous solutions.
- Cyclodextrins can potentially inhibit protein aggregation by interacting with aromatic residues.
Purpose of the Study:
- To investigate the interaction between hydroxypropyl-beta-cyclodextrin (HPBCD) and melittin.
- To determine if HPBCD can inhibit melittin aggregation.
- To elucidate the mechanism of HPBCD's inhibitory effect on protein aggregation.
Main Methods:
- Steady-state and time-resolved fluorescence spectroscopy
- Fluorescence polarization
- Circular dichroism (CD) spectroscopy
- Infrared (IR) spectroscopy
Main Results:
- HPBCD effectively inhibits the aggregation of melittin.
- Spectroscopic data indicate that HPBCD intercalates the aromatic tryptophan residue of melittin.
- The findings support the hypothesis that HPBCD competes with interprotein pi-pi interactions, thus preventing aggregation.
Conclusions:
- HPBCD is an effective inhibitor of melittin aggregation.
- The mechanism of inhibition involves the intercalation of melittin's aromatic tryptophan residue within the HPBCD cavity.
- This study provides evidence for the utility of cyclodextrins in preventing protein aggregation through molecular encapsulation.